Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `jetpack` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/grassnews/public_html/wp-includes/functions.php on line 5905
Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A – GrassNews
Connect with us

Cannabis

Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A

Published

3 years ago

on

Oakville, Ontario–(Newsfile Corp. – March 26, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company“), a leader in the production of pharmaceutical cannabidiol (CBD) and the development of innovative cannabidiol medicines for heart disease, today filed its audited Year-end Financial Statements and Management’s Discussion and Analysis for the year ended December 31, 2019. Both are available under the Company’s profile on SEDAR at www.sedar.com and on the Company’s website at www.cardiolrx.com.

“2019 was a pivotal year for Cardiol Therapeutics,” stated David Elsley, President and CEO. “We attracted industry-leading talent to our management team, world class stewardship and experience to our Board of Directors, and global thought leaders in cardiology to the Steering Committee for our Phase 2 international trial in acute myocarditis. We also established the commercial infrastructure and pharmaceutical supply chain necessary to support the commercial launch of the purest cannabidiol in the world – a product specifically formulated for consistency, stability, and purity to meet the needs of millions of people who should not be exposed to THC.

The Company’s most significant achievement to date followed our 2019 fiscal year end with the signing of an exclusive supplier agreement with Canada’s largest pharmacy retailer, Shoppers Drug Mart, to supply our pharmaceutical cannabidiol formulation to patients nationwide. Formulated purely for medical purposes and manufactured under the most stringent quality standards set by the pharmaceutical industry, the commercialization of our pharmaceutical high purity, THC free (<5ppm) cannabidiol oil aims to address a growing market need for patients who should not be exposed to THC.

2020 is expected to witness significant growth for Cardiol, as the Company builds brand awareness of the purest pharmaceutical cannabidiol formulation in the world with its commercial launch in Canada’s $1.2 billion medicinal cannabinoids market, the development of plans for expansion into Europe and Latin America, and the initiation of its international trial in patients with acute myocarditis, an inflammatory form of heart failure that represents a leading cause of sudden cardiac death in children and young adults. This international study is being planned at world-leading heart institutes, including the Cleveland Clinic, the Mayo Clinic, the Houston Methodist DeBakey Heart and Vascular Center, the University of Ottawa Heart Institute, the University of Pittsburgh Medical Center, and Charité Hospital Berlin.

Highlights during the 2019 Fiscal Period

  • The appointment of Mr. Thomas Moffatt, BBA, as Chief Commercial Officer. Mr. Moffatt is a senior operations and retailing executive with an extensive background in the pharmacy retail space. Mr. Moffatt spent more than 20 years with Shoppers Drug Mart (“Shoppers”) where, as National Vice-President Operations and Strategy, he led the repositioning of Shoppers in the Canadian market. Mr. Moffatt was most recently the Chief Operating Officer and Vice-President, Operations at Rx Drug Mart Inc., where he was responsible for the growth, marketing and development of all operations for more than 45 stores, including marketing, personnel and strategic activities.
  • The appointment of Andrea B. Parker, MSc, PhD, as Director of Clinical Affairs. Dr. Parker is a Clinical Epidemiologist with more than 30 years’ experience in clinical trials design, management, and execution in industry and academic settings. She was involved in the organization and execution of many large-scale international clinical trials, specializing in cardiovascular disease, pain management, and imaging techniques and is the former Chief Scientific Officer at Peter Munk Cardiac Centre, University Health Network. Dr. Parker holds a MSc in Clinical Epidemiology from Harvard School of Public Health and a PhD in Medical Sciences from the University of Toronto.
  • The completion of the manufacturing scale-up for commercialization of the Company’s CardiolRx 100 cannabidiol formulation. CardiolRx 100 (100 mg/mL CBD with 3,000 mg of cannabidiol per bottle) is designed to be the safest and most consistent high concentration cannabidiol formulation available to Canadians that is THC free (<5ppm). It is pharmaceutically produced in a Health Canada approved, FDA registered and inspected, cGMP facility.

  • The formation of a Clinical Steering Committee, comprising world-renowned key opinion leaders in acute myocarditis from North America and Europe, for a Phase 2 international trial in acute myocarditis using the Company’s CardiolRx 100 cannabidiol formulation.

  • The appointment of Mr. Colin Stott to Cardiol’s Board of Directors. Mr. Stott is the former Scientific Affairs Director, International and R&D Operations Director for GW Pharmaceuticals plc, a world leader in the development of cannabinoid therapeutics that created Epidiolex®, the first FDA-approved cannabidiol therapy for use as an orphan drug in the treatment of rare forms of paediatric epilepsy.

Highlights Subsequent to Year-End

  • The signing of a supplier agreement to become a medical cannabidiol supplier to Shoppers, Canada’s national pharmacy retailer. Under the terms of the agreement, the Company will supply Cardiol’s pharmaceutical cannabidiol products to Shoppers for sale in all provinces and territories in Canada through Shoppers’ online store, Medical Cannabis by Shoppers. Products will be sold initially in three dosage formats: 100mg/mL, 50mg/mL, and 25mg/mL. Shoppers also has the right to purchase all future products available from Cardiol’s product line, subject to any and all regulations.

  • The receipt of a No Objection Letter from Health Canada to conduct a Phase 1 study of the Company’s pharmaceutically produced high concentration, pure cannabidiol formulation. The Company plans to initiate the study in Q2, 2020. The Phase 1 study is designed to measure the pharmacokinetics (blood levels of drug) following single and multiple doses of the Company’s extra strength 100mg/mL concentration pharmaceutical cannabidiol formulation in up to up to 55 healthy subjects, both in the fasting and fed states. The study will also measure standard safety parameters at escalating doses to help select the optimal dosing levels for the Company’s planned international Phase 2 study in acute myocarditis later this year.

Outlook for 2020

The Corporation expects that its current working capital will be sufficient to fund operations and capital requirements through March 31, 2021, notwithstanding its plans to generate revenues in the Canadian and international markets.

During the remainder of 2020, Cardiol expects the following catalysts for growth:

  1. The commercial launch throughout Canada of the Company’s pharmaceutical cannabidiol, which is expected to set a new industry standard for product purity and consistency.

  2. The initiation of a clinical trial program to begin in H2 2020, designed to demonstrate impact of the Company’s proprietary pharmaceutical cannabidiol formulation on acute myocarditis.

  3. The development of global expansion plans to support the commercialization of CardiolRx pharmaceutical cannabidiol in Europe and Latin America.

About Cardiol Therapeutics

Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) is focused on producing pharmaceutical cannabidiol (CBD) products and developing innovative therapies for heart diseases, including acute myocarditis and other causes of heart failure. The Company’s lead product, CardiolRx™, is formulated to be the most consistent cannabidiol formulation on the market. CardiolRx is pharmaceutically produced, manufactured under cGMP, and is THC free (<5 ppm). The Company also plans to commercialize CardiolRx in the billion-dollar market for medicinal cannabinoids in Canada and is pursuing distribution opportunities in Europe and Latin America.

In heart failure, Cardiol is planning an international clinical study of CardiolRx in acute myocarditis, a condition caused by inflammation in heart tissue, which remains the most common cause of sudden cardiac death in people less than 35 years of age. The Company is also developing proprietary nanotechnology to uniquely deliver pharmaceutical cannabidiol and other anti-inflammatory drugs directly to sites of inflammation in the heart associated with heart failure. Heart failure is the leading cause of death and hospitalization in North America with associated annual healthcare costs in the U.S. alone exceeding $30 billion. For further information about Cardiol Therapeutics, please visit cardiolrx.com.

For further information, please contact:

David Elsley, President & CEO +1-289-910-0850
david.elsley@cardiolrx.com

Trevor Burns, Investor Relations +1-289-910-0855
trevor.burns@cardiolrx.com

Cautionary statement regarding forward-looking information:

This news release contains “forward-looking information” within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, that address activities, events or developments that Cardiol Therapeutics Inc. (“Cardiol”) believes, expects or anticipates will, may, could or might occur in the future are “forward- looking information”. Forward-looking information is frequently identified by the use of words such as “plans”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “forecasts”, and other similar words and phrases, including variations (and negative variations) of such words and phrases, or may be identified by statements to the effect that certain actions, events or conditions “may”, “could”, “should”, “would”, or “will” be taken, occur or be achieved. Forward-looking information contained herein may include, but is not limited to, statements with respect to: future events; the future performance or the intended business strategy of Cardiol, including, but not limited to, the plan to commercialize CardiolRx™100 and the planning of an international clinical study of CardiolRx in acute myocarditis; the potential for Cardiol’s licensed drug encapsulation and delivery technologies to enhance the bioavailability of pharmaceuticals; management’s expectations regarding estimated future pharmaceutical research and development opportunities, collaborations and prospects; the success and proposed timing of Cardiol’s product development activities; the ability of Cardiol to develop its product candidates; Cardiol’s plans to research, discover, evaluate and develop additional products; Cardiol’s proposed future collaborations to advance Cardiol’s lead nanoformulations into clinical development; and the potential for Cardiol’s cannabinoid-based products to provide sources of future revenue. Forward-looking information contained herein reflects the current expectations or beliefs of Cardiol based on information currently available to it and is subject to a variety of known and unknown risks and uncertainties and other factors that could cause the actual events or results to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information. These risks and uncertainties and other factors include that the success of Cardiol’s product candidates will require significant capital resources and years of clinical development efforts; the results of clinical testing and trial activities of Cardiol’s products; Cardiol’s ability to obtain regulatory approval and market acceptance of its products; Cardiol’s ability to raise capital and the availability of future financing; Cardiol’s lack of operating history; unforeseeable deficiencies in the development of Cardiol’s product candidates; uncertainties relating to the availability and costs of financing needed in the future for Cardiol’s research and development initiatives; Cardiol’s ability to manage its research, development, growth and operating expenses; the potential failure of clinical trials to demonstrate acceptable levels of safety and efficacy of Cardiol’s product candidates; Cardiol’s ability to retain key management and other personnel; risks related to fluctuations in medicinal cannabinoid markets in Canada and worldwide; uncertainties regarding Cardiol’s ongoing collaborative and manufacturing partnerships; uncertainties regarding results of researching and developing products for human use; Cardiol competes in a highly competitive and evolving industry; Cardiol’s ability to obtain and maintain current and future intellectual property protection; and other risks and uncertainties and factors. These risks, uncertainties and other factors should be considered carefully, and investors should not place undue reliance on the forward-looking information. Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable securities laws, Cardiol disclaims any intent or obligation to update or revise such forward-looking information, whether as a result of new information, future events or results or otherwise. Although Cardiol believes that the expectations reflected in the forward-looking information are reasonable, they do involve certain assumptions, risks, and uncertainties and are not (and should not be considered to be) guarantees of future performance. It is important that each person reviewing this news release understands the significant risks attendant to the operations of Cardiol.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/53858

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis

New to The Street Announces its Five Corporate Interviews, airings on Newsmax and FOX Business Network

Published

2 days ago

on

September 22, 2023

By

NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) — FMW Media’s New to The Street, a premier business television show, announces their featured corporate lineups on shows 512 and 513. Each show is to air across New to The Street’s televised platforms on Newsmax and the FOX Business Network.

New to The Street airs on Newsmax, Episode 512, on Saturday, September 23, 2023, at 3:30 PM ET, and the FOX Business Network, Episode 513, on Monday, September 25, 2023, at 10:30 PM PT, featuring the following five (5) Corporate interviews:

1). American Made Products – American Rebel Holdings, Inc.’s (NASDAQ: AREB) ($AREB) interview with Andy Ross, Chairman/CEO.

2). E-commerce/ Digital Marketing – Society Pass Incorporated’s (NASDAQ: SOPA) ($SOPA) interview with Rokas Sidlauskas, Chief Marketing Officer.

3). Health Sciences – PreveCeutical Medical, Inc.’s (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF) interview with Stephen Van Deventer, Chairman/CEO.

4). Artist – Hope Tain Oil Painting’s interview with Hope Tain, Artist/Owner.

5). “Sekur Privacy & Sekur Security Segment – The Weekly Hack” interview with internet privacy expert Mr. Alain Ghiai, CEO, Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) (Sekur®).

America Rebel Holdings, Inc.’s (NASDAQ: AREB) ($AREB) Chairman/CEO Andy Ross is with New to The Street’s TV Host Jane King. From the Nasdaq MarketSite studio, Andy talks about AREB, a NASDAQ publicly traded company that makes “American Made” products. Recognized as “America’s Patriotic Brand,” the Company has several product lines, including safes. A recent FBI raid on the home of a suspected participant on January 6, 2021, at the US Capitol Building revealed a disturbing issue. A competitor’s safe, Liberty Safe, was in the home, and the FBI contacted that manufacturer about the make and model and then Liberty handed over data to open the safe without proper legal premise. Andy explains to viewers that the Company would request appropriate legal service if the FBI contacted American Rebel regarding its Champion safe. Andy informs viewers that American Rebel believes in the United States’ Constitution and those rights inherent to Americans. Privacy is essential to every American, and if the FBI served the Company, Management would fight the legal subpoena under constitutional grounds. American Rebel would never hand over proprietary safe codes.. Demand is up for the Champion’s safes because of this FBI incident. American Rebel’s Champion Safes are affordable and reliable. Another soon-to-launch American Rebel product, “American Rebel Beer,” is coming to market. The US Beer market generates around $44B yearly, and American Rebel Beer is looking forward to breaking into the US Beer market. The roll-out of its lager and light beers will be regional, with the expectation of becoming national in 2024. It is working on other beer flavors, with roll-outs expected in the months ahead. During the Show, Andy announces his new Music CD, “I Stand for You,” which can be heard on airwaves or downloaded digitally. The American Rebel Beer jingle will air soon. Viewers can learn more about the Company’s mission and products through its strong social media presence, websites, and websites like www.americanrebel.com and www.andyross.com. The on-screen QR code is available during the show; download or visit America Rebel, Inc. – http://www.americanrebel.com/.

From the Nasdaq MarketSite studio, Rokas Sidlauskas, Chief Marketing Officer of Society Pass Incorporated (NASDAQ: SOPA) ($SOPA) (“Society Pass”) talks with New to The Street’s TV Host Jane King about SOPA. With a focus on acquisitions and growing its next-generation digital e-commerce platform, SOPA continues to onboard businesses and individuals throughout Southeast Asia. Rokas explains that with about 650 million people, SE Asia is a strong growing market, and SOPA has positioned itself to take advantage of this demographic. SOPA has business operations in Vietnam with a population of 100M, and about 55% are under 30. With a highly tech-savvy population, SE Asia embraces technology and digital solutions. The Company’s loyalty program can be interchangeable in other countries. Through SOPA’s business verticals in retail goods, fintech, telecom, travel, food/beverage, and digital marketing, Rokas gives an example where travel rewards in one country are available to purchase retail products in a different country. SOPA has business operations in Singapore, Vietnam, Philippines, Indonesia, and Thailand and is looking into expanding into Malaysia. 70% of the SE Asian population does not have a conventional banking account; they use digital wallets for purchases. Rokas believes SOPA has opportunities to expand its digital ecosystem to the “Unbanked.” The Company continues executing its business plan and wants to increase its digital ecosystem loyalty program. The loyalty app is available for iOS and Android downloads. The on-screen QR code is available during the show; download or visit Society Pass Incorporated – https://thesocietypass.com/.

PreveCeutical Medical, Inc.’s (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF) (“PreveCeutical”) Chairman and CEO Stephen Van Deventer talks with New to The Street’s TV Host Jane King. PreveCeutical is a medical science company that develops innovative options for preventive and curative therapies using natural and organic compounds. The Company can synthesize molecular organic compounds through its proprietary technology and extensive peptide library to create preventative medical solutions. Using the technology, PreveCeutical developed a compound tested on mice, providing pre-clinical results on a non-addictive pain treatment more potent than opioids and morphine with no significant side effects. A pharmaceutical journal published a peer-review of the pre-clinical results. Stephen has a background in investment banking and was involved in the cannabis industry. He was involved with Aurora Cannabis Company and is passionate about finding organic and natural medical preventative solutions. The scientific team at PreveCeutical consists of doctors, PhDs, and engineers, all with impressive credentials in the pharmacology and pharmaceutical industries. With pre-clinical solid data, the team is moving forward on a clinical trial with the hopes of obtaining fast-track regulatory approvals in the US, Europe, and Australia for commercial distribution of a novel non-addictive pain management drug. The on-screen QR code is available during the show; download or visit PreveCeutical Medical, Inc. – https://www.preveceutical.com/.

New to The Street’s TV Host Jane King, from the Nasdaq MarketSite studio, interviews Hope Tain, Artist/Owner of Hope Tain Oil Painting. Hope was born and raised in Beijing, China, and in the late 1990s she moved to the US to pursue her graduate degree in New York State. In 2011, Hope painted a portrait for her son as his birthday gift; she realized her talent and pursued her art career. As self-taught and working with oil, Tain creates beautiful art depicting portraits, landscapes, seascapes, and still life, anything that inspires her. Tain explains that she visualizes each oil canvas painting before beginning each artwork. Inspirations can come from the Master artists or the simplest of events in her life, but LOVE provides her with the most inspiration for her creativity. Art taught Hope anything is possible, and pursuing her passion becomes a fulfilling career. She is grateful for her family, friends, other artists, and the art gallery communities, all providing support and influential inspiration for her oils. Currently living in Massachusetts, artwork done by Hope Tain is available for sale, or you can commission her talent for your unique and personal piece of art. The on-screen QR code is available during the show; download or visit Hope Tain Oil Painting – https://www.hopetianart.com/.

This week’s New to the Street TV “Weekly Sekur Privacy & Sekur Security Segment” with internationally acclaimed internet privacy expert Mr. Alain Ghiai, CEO of Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) and TV Host / Multi-media Journalist Ana Berry discuss the most recent “Phishing” attack. Ana recently received a suspicious text message disguised as genuine from the United States Postal Service (USPS). Phishing is occurring on text messaging platforms, with the hacker’s objective for one to click the message link so malware downloads on the device. Alain states that Phishing increased rapidly during and after COVID because of the increased demand for online purchasers. During checkout, most sites ask for a phone number; the hackers have that information and now try to entice the unaware to click links on text messages. Sekur’s cybersecurity products never ask for a phone number. SekurVPN, SekurMail, and SekurMessenger, each with unique features, can significantly minimize the threat of becoming a cybersecurity victim. The SekurMessenger comes with the “Chat-by-Invite” feature, which allows for a close-loop, encrypted platform protecting the subscriber and chat recipient from a possible hack. The whole text message is within Sekur’s servers located in Switzerland. The “Chat-by-Invite” is available for use in 80 countries. SekurMail, with its SekurSend/SekurReply feature, offers subscribers another excellent option for secure encrypted communications. Alain believes that to enhance your internet invisibility and greatly diminish your web footprint, use the Company’s SekurVPN service; subscribers get a Swiss IP address. The Company is offering PROMO CODE: PRIVACY; subscribers can get an additional 15% off monthly and yearly subscriptions for five years. Sekur Private Data, Ltd. does no data mining, no internet traffic tracking, no shared servers, no open-platform coding, and no third-party providers, and never asks for a phone number, and the Company owns and operates its servers in Switzerland, a country with strict privacy laws. The on-screen QR code is available during the shows to download more info or visit Sekur Private Data, Ltd. – https://sekurprivatedata.com/, http://www.Sekur.com and https://www.sekurvpn.com/. “What is your privacy worth?”

About American Rebel Holdings, Inc. (NASDAQ: AREB) ($AREB):

American Rebel Holdings, Inc. (NASDAQ: AREB) ($AREB) operates primarily as a designer, manufacturer, and marketer of branded safes and personal security and self-defense products. The Company also designs and produces branded apparel and accessories – www.americanrebel.com & www.americanrebel.com/investor-relations.

About Society Pass Incorporated (NASDAQ: SOPA) ($SOPA):

Founded in 2018 as a data-driven loyalty, fintech, and e-commerce ecosystem in the fast-growing markets of Vietnam, Indonesia, Philippines, Singapore, and Thailand, which account for more than 80% of the Southeast Asia (SEA) population, and with offices located in Los Angeles, Bangkok, Ho Chi Minh City, Jakarta, Manila, and Singapore, Society Pass Incorporated (NASDAQ: SOPA) is an acquisition-focused holding company operating six interconnected verticals (loyalty, digital media, travel, telecoms, lifestyle, and F&B), which seamlessly connects millions of registered consumers and hundreds of thousands of registered merchants/brands across multiple product and service categories throughout SEA. Society Pass leverages technology to tailor a more personalized experience for customers in the purchase journey and transform the entire SEA retail value chain. SOPA operates Thoughtful Media Group, a Thailand-based, social commerce-focused, premium digital video multi-platform network; NusaTrip, a leading Indonesia-based Online Travel Agency; Gorilla Networks, a Singapore-based, web3-enabled mobile blockchain network operator; Leflair.com, Vietnam’s leading lifestyle e-commerce platform; Pushkart.ph, a popular grocery delivery company in the Philippines; Handycart.vn, a leading online restaurant delivery service based in Vietnam; and Mangan.ph, a leading local restaurant delivery service in Philippines – https://thesocietypass.com/.

About PreveCeutical Medical, Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF):

PreveCeutical Medical, Inc. (OTCQB: PRVCF) (CSE: PREV) (FSE: 18H) ($PRVCF) is a health sciences company that develops innovative options for preventive and curative therapies utilizing organic and nature-identical products. The Company aims to be a leader in the preventive health sciences sector. With the completion of three of its research programs, the Company is actively working on the development, clinical trials, and commercialization of its products and has filed several provisional patent applications to protect the intellectual property from its research programs – https://www.preveceutical.com/.

About Hope Tain Oil Painting:

Hope Tain Oil Painting’s Artist/Owner, Hope Tian, finds great excitement and creativity in exploring varied subjects and eclectic oil painting styles.  Her artwork ranges from impressionistic or post-impressionistic to expressionistic or fauvist to truly representational to abstract.  Hope’s paintings are heavily influenced by her keen interest in and ongoing study of master painters. Standing before Hope Tian’s original oil painting, there is a deep emotional expression, creatively textured layering, vividly vibrant colors, and lively free brush strokes ranging from the lightest touch to heavy, thick paint, all resulting in a unique artistic experience – https://www.hopetianart.com/.

About Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF):

Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) ($SWISF) is a cybersecurity and internet privacy provider of Swiss-hosted solutions for secure communications and secure data management. The Company distributes a suite of secure cloud-based storage, disaster recovery, document management, encrypted emails, and secure communication tools. It sells its products through its websites, www.sekur.com, approved distributors, and telecommunication companies worldwide. Sekur Private Data, Ltd. serves consumers, businesses, and governments worldwide – https://www.sekurprivatedata.com and https://www.sekur.com; Twitter: @sekurprivate.

About New to The Street:

New to The Street is an FMW Media production that operates one of the longest-running US and International sponsored and syndicated Nielsen-rated programming television brands, “New to The Street. Since 2009, New to The Street has run biographical interview segment shows across major U.S. television networks. The Nielsen Rated and sponsored broadcasts programming platform reaches millions of homes in the US and international markets. FMW’s New to The Street / Newsmax televised broadcasting platform airs its syndication on Saturdays at 3:30 – 4:00 PM ET. The show also appears on Bloomberg and the FOX Business Network as sponsored programming. FMW is also one of the nation’s largest buyers of linear television, long and short-form paid programming – https://www.newsmaxtv.com/Shows/New-to-the-Street, https://www.newtothestreet.com/ & https://www.youtube.com/watch?v=4-G2–mRQUw&t=14s.

Forward-Looking Statements Disclaimer US/Canada:

This press release contains forward-looking statements within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology. However, not all forward-looking statements contain these words. Forward-looking statements do not guarantee future performance or results and will not necessarily be accurate indications of when such performance or results are achieved. This press release should be considered in all filings of the Companies contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

This press release contains forward-looking information within the meaning of applicable Canadian securities laws. Forward-looking information is often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. These statements reflect management’s current beliefs and are based on information currently available to management as of the date hereof. Forward-looking information in this press release includes, without limiting the foregoing, expectations regarding agents that join Real. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CONTACT:

FMW Media Contact:
Monica Brennan
monica@NewtoTheStreet.com
1-917-330-2564

“New to The Street” Business Development Office
1-516-696-5900
Support@NewToTheStreet.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/a4b7c17b-6423-479b-a6df-538a9d6f9969

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7d40201e-691f-48b2-9547-21f579bda0bb

Continue Reading

Cannabis

CBD Skin Care Market Size is projected to reach USD 6466.43 million by 2030, growing at a CAGR of 32.15%: Straits Research

Published

4 days ago

on

September 20, 2023

By

New York, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) — Cannabidiol (CBD), derived from cannabis resin, is non-intoxicating. Cannabinoid (CBD) is most typically used with oils. CBD oil has anti-inflammatory, antioxidant, and skin-soothing properties. CBD oil is currently a popular ingredient in skin care and personal care products.

Since marijuana and cannabis-based cosmetics were legalized, CBD-infused skin care products have gained popularity. CBD-infused skin care products are popular because they relax. Anti-inflammatory and anti-oxidant properties make it a promising skin care ingredient. CBD-based skincare products can improve sleep and treat eczema, psoriasis, and acne. CBD-based skin care is popular among cosmetic brands. CBD-infused skin care is marketed as “natural cosmetics” CBD skin care products are expected to become popularity due to their versatility.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cbd-skin-care-market/request-sample

Global CBD Skin Care Market: DRIVERS

  • Cannabis-Derived Skin Care Products Are Gaining Popularity

A surge in the working population around the world has increased spending power and awareness of the range of commodities on the market, boosting sales of quality products. These factors have led to growing global demand for natural and organic personal care items.

People are becoming increasingly familiar with the benefits of CBD skin care products, such as CBD oil in their daily coffee, using it to their skin to relieve pain, consuming it to relieve anxiety, and using it in their sex life.

  • Social-Media’s Impact on Skin Diseases

Because of pollution and UV radiation, which can cause skin burns, blackening, and cancer, consumers are turning to CBD-infused cosmetics and skincare products. Consumers’ increased acquaintance with the newest skin care products helps boost sales. Companies increasingly use celebrities to sell their products and spend a lot on advertising.

YouTube and Instagram are important influences on today’s society. These portals help people find CBD skin care products. Rising customer awareness of the benefits and availability of new products should benefit the global market in the futur

Global CBD Skin Care Market: KEY FUTURE OPPORTUNITIES

  • Technological Advances and Mergers Create New Opportunities

Recent scientific advances have resulted to innovative CBD extracts and combinations for skin care. CBD-infused goods from multinational firms are capturing new markets and establishing new cash streams. Avon plans to develop vegan skin care products with CBD oil in 2020. As the cannabis beauty industry grows, component approaches vary. These factors boost market growth.

A growing number of technological innovations are driven by a desire to lower production costs and to foster sustainable growth from 2022 to 2030.

Report Scope

Report Metric Details
Market Size by 2030 USD 6466.43 million
Market Size in 2021 USD 526.09 million
CAGR 32.15% (2022-2030)
Historical Data 2020-2021
Base Year 2022
Forecast Period 2023-2031
Forecast Units Value (USD million)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Technology, By Application, By Location
Geographies Covered North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors Kiehl’s LLC, Medical Marijuana, ENDOCA, Elixinol Global ltd, Lord Jones, Icanic Brands Company, Inc., LEEF Organics, The CBD Skincare Co, Kana Skincare, Apothecana, Josie Maran Cosmetics, FOLIUM BIOSCIENCES, CBD for life, Pacific Roots LLC,
Key Market Opportunities Technological Advances and Mergers Create New Opportunities
Key Market Drivers Cannabis-Derived Skin Care Products Are Gaining Popularity

Buy Now Full Report @ https://straitsresearch.com/buy-now/cbd-skin-care-market

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa make up the CBD Skin Care Market.

North America, which had over 45% of the market in 2021, is expected to grow quickest. Demand for CBD skin care products in North America is expected to continue high due to a large client base and the legalization of marijuana. Due to legalization in 33 states and DC, the US possesses the world’s largest cannabis market. Cannabis legalization and well-known beauty product makers should boost industry growth in the next years.

CBD-infused skin care products may fuel US customer demand. The FDA Regulation of Cannabidiol (CBD) Products prohibits marijuana but not hemp or cannabis. Manufacturing and selling CBD derivatives is lawful. CBD derivatives may be used as lotions, serums, and ointments.

Asia Pacific will grow rapidly in the future years. China, India, Japan, and Korea are expected to see substantial growth. J-beauty and K-beauty lead the worldwide skincare market, despite cannabis being illegal in Asia. This market is expected to grow rapidly in Asia.

China is one of the main manufacturers of cannabis made from hemp, and the World Bank and IMF expect it to monopolize the market throughout the predicted period. China allows the production and sale of CBD products with a maximum 0.3% THC content from cannabis Sativa fruit, seed oil, and leaf extract. This benefits its use in high-end skincare and luxury cosmetics.

Due to changing legislation, India’s CBD skin care market is growing. The Narcotic Drugs and Psychotropic Substances Act of 1985 says it’s unlawful to produce cannabis in the U.S., although states can allow its commercial or research cultivation.

Key Highlights

  • The Global CBD Skin Care Market size is predicted to reach at USD 6466.43 million by 2030, increasing at a CAGR of 32.15% from 2022 to 2030.
  • By Source,the Global CBD Skin Care Market is segmented into Hemp and Marijuana. CBD skin care products derived from hemp maintained the biggest market share.
  • By Type,the Global CBD Skin Care Market is segmented into Oils, Creams & Moisturizers, Masks & Serums, Cleansers, and Others. In 2021, the market was led by skin care oils containing CBD.
  • By Region,the Global CBD Skin Care Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market share is dominated by North America.

Major Players in Global CBD Skin Care Market

  1. Kiehl’s LLC
  2. Medical Marijuana
  3. ENDOCA
  4. Elixinol Global ltd
  5. Lord Jones
  6. Icanic Brands Company, Inc.
  7. LEEF Organics
  8. The CBD Skincare Co
  9. Kana Skincare
  10. Apothecana
  11. Josie Maran Cosmetics
  12. FOLIUM BIOSCIENCES
  13. CBD for life
  14. Pacific Roots LLC
  15. Ecogen labs

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/cbd-skin-care-market/request-sample

Global CBD Skin Care Market: Segmentation

BY SOURCE

  • Hemp
  • Marijuana

BY TYPE

  • Oils
  • Creams & Moisturizers
  • Masks & Serums
  • Cleansers
  • Others

BY GEOGRAPHY

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Latin America
  • Middle East and Africa (MEA)

TABLE OF CONTENT

  1. EXECUTIVE SUMMARY
  2. RESEARCH SCOPE & SEGMENTATION
    1. Research Objectives
    2. Market Definition
    3. Limitations & Assumptions
    4. Market Scope & Segmentation
    5. Currency & Pricing Considered
  3. MARKET OPPORTUNITY ASSESSMENT
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    4. Investment Landscape
    5. New Business Models / Revenue Streams
    6. TAM
  1. MARKET TRENDS
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Human Factors
    6. Technology Factors
  1. MARKET ASSESSMENT
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    3. Sales And Distribution Channel Analysis
    4. Average Pricing Analysis
    5. Patent Analysis
    6. M & A Agreements & Collabration Analysis
    7. Export Import Analysis
  1. ESG TRENDS
  2. GLOBAL CBD SKIN CARE MARKET SIZE ANALYSIS
    1. Global CBD Skin Care Market Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
  1. NORTH AMERICA MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. U.S.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Canada
  1. EUROPE MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. U.K.
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Germany
    2. France
    3. Spain
    4. Italy
    5. Russia
    6. Nordic
    7. Benelux
    8. Rest Of Europe
  1. APAC MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. China
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Korea
    2. Japan
    3. India
    4. Australia
    5. Taiwan
    6. South East Asia
    7. Rest Of Asia-Pacific
  1. MIDDLE EAST AND AFRICA MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. UAE
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Turkey
    2. Saudi Arabia
    3. South Africa
    4. Egypt
    5. Nigeria
    6. Rest Of MEA
  1. LATAM MARKET ANALYSIS
    1. Introduction
    2. By Source
      1. Introduction
        1. Source By Value
      1. Hemp
        1. By Value
      1. Marijuana
        1. By Value
    1. By Type
      1. Introduction
        1. Type By Value
      1. Oils
        1. By Value
      1. Creams & Moisturizers
        1. By Value
      1. Masks & Serums
        1. By Value
      1. Cleansers
        1. By Value
      1. Others
        1. By Value
    1. Brazil
      1. By Source
        1. Introduction
          1. Source By Value
        2. Hemp
          1. By Value
        3. Marijuana
          1. By Value
      1. By Type
        1. Introduction
          1. Type By Value
        2. Oils
          1. By Value
        3. Creams & Moisturizers
          1. By Value
        4. Masks & Serums
          1. By Value
        5. Cleansers
          1. By Value
        6. Others
          1. By Value
    1. Mexico
    2. Argentina
    3. Chile
    4. Colombia
    5. Rest Of LATAM
  1. COMPETITIVE ASSESSMENT
    1. CBD Skin Care Market Share By Manufacturers
    2. CBD Skin Care Market Ranking By Revenue For Manufacturers
    3. Competitive Dashboard
    4. Product Mapping
  1. MARKET PLAYERS ASSESSMENT
    1. Kiehl’s LLC
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. Gross Margin
      6. Swot Analysis
      7. Recent Developmments
    1. Medical Marijuana
    2. ENDOCA
    3. Elixinol Global Ltd
    4. Lord Jones
    5. Icanic Brands Company, Inc.
    6. LEEF Organics
    7. The CBD Skincare Co
    8. Kana Skincare
    9. Apothecana
    10. Josie Maran Cosmetics
    11. FOLIUM BIOSCIENCES
    12. CBD For Life
    13. Pacific Roots LLC
    14. Ecogen Labs
  1. RESEARCH METHODOLOGY
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data From Secondary Sources
      1. Primary Data
        1. Key Data From Primary Sources
        2. Breakdown Of Primaries
      1. Secondary And Primary Research
        1. Key Industry Insights
    1. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    1. Research Assumptions
      1. Assumptions
    1. Limitations
    2. Risk Assessment
  1. APPENDIX
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  1. DISCLAIMER

Table of Content and Figure @ https://straitsresearch.com/report/cbd-skin-care-market/toc

News Media

Global CBD Skin Care Market Extends at a Healthy CAGR of 32.15%

Consumer Preference Drives the CBD Skin Care Products Market despite the Stringent Regulatory Landscape in Many Countries

Have a Look at the Related Research Report

Skincare Products Market: Information by Product Type (Facial Care, Lip Care, and Body Care), Category (Premium Skincare Products and Mass Skincare Products), and Region- Forecast till 2030

Skincare Body Products Market: Information by Gender (Male and Female), Product (Face Creams and Moisturizers), and Region — Forecast till 2030

Organic Skin Care Market: Information by Product (Face Cleanser, Face Serum), Distribution Channel (Online, Supermarket/Hypermarket), and Region — Forecast till 2030

Facial Skincare Products Market: Information by Product Type (Facial Cleanser, Toner, Facial Serum, Eye Creams), Distribution Channel (Specialty Stores), and Region — Forecast till 2030

About Straits Research Pvt. Ltd.

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 905 0080 (the U.S.)

+91 8087085354 (APAC)

+44 203 695 0070 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter

Continue Reading

Cannabis

Legal Cannabis Commercialization Bolsters Vacuum Oven Demand; Essential Role in Processing Extracts and Enhancing Safety Recognized

Published

4 days ago

on

September 20, 2023

By

Dublin, Sept. 20, 2023 (GLOBE NEWSWIRE) — The “Vacuum Ovens Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” report has been added to ResearchAndMarkets.com’s offering.

The global vacuum ovens market exhibited strong growth in 2022, reaching a total valuation of US$ 234.3 million. According to this report the market is poised for continued expansion, with expectations to reach US$ 343.2 million by 2028. This growth reflects a robust compound annual growth rate (CAGR) of 6.38% during the forecast period from 2023 to 2028.

Vacuum ovens, highly versatile equipment with applications in laboratory research, engineering, and industry, play a pivotal role in the heat treatment process. These ovens conduct heat treatment within an airtight vessel, allowing the creation of a vacuum within the chamber. This capability enables precise control over the heat treatment process and offers several advantages, including:

  1. Prevention of surface reactions like oxidation or decarburization.
  2. Removal of surface contaminants such as oxide films and residual traces of lubricants.
  3. Introduction of substances to the surface layers of the work.
  4. Removal of dissolved contaminating materials from metals through degassing.

The vacuum oven market’s growth is closely tied to the legalization of cannabis in many parts of the world and the subsequent commercialization of related products. Vacuum ovens play a crucial role for legal cannabis growers in processing cannabis extract BHOs (Butane Hash oil).

These ovens enable the production of purified oil extracts while reducing the risk of fires during the extraction process. Furthermore, vacuum ovens are used in the medical industry to eliminate potentially toxic chemicals from medical devices, including artificial heart valves, pacemakers, and joint implants. These ovens also find application in testing how devices respond to the high vacuum environment of space, making them valuable equipment for the aerospace industry.

Key Market Segmentation:

The global vacuum ovens market report by [Publisher Name] analyzes key trends within each sub-segment and provides forecasts at the global and regional levels for the period from 2023 to 2028. The market is segmented based on product type and application.

Product Type:

  • < 200
  • 200-300
  • > 300

Application:

  • Home Appliances
  • Commercial Appliances

Regional Insights:

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

The report offers a comprehensive analysis of the competitive landscape, featuring key players such as Cole-Parmer, Memmert GmbH+Co.KG, MTI Corporation, Sheldon Manufacturing Inc, Thermo Fisher Scientific, Accumax India, BINDER GmbH, Cascade TEK, ESPEC, Grieve, JEIO, SalvisLab Renggli, Shanghai Hasuc Instrument, Ted Pella, and Yamato Scientific.

This report provides in-depth insights into the global vacuum ovens market, covering macro overviews, micro details of industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, and more. It is a crucial resource for entrepreneurs, investors, researchers, consultants, business strategists, and anyone involved or planning to enter the vacuum ovens industry.

Key Questions Answered in This Report:

  • How has the global vacuum ovens market performed and what are the growth prospects in the coming years?
  • Which regions are the primary markets in the global vacuum ovens industry?
  • What impact has COVID-19 had on the global vacuum ovens industry?
  • How is the global vacuum ovens market segmented based on product type?
  • What are the applications driving the global vacuum ovens market?
  • What are the price trends for vacuum ovens?
  • What is the value chain structure of the global vacuum ovens market?
  • What are the key factors driving growth and challenges in the global vacuum ovens market?
  • Who are the major players in the global vacuum ovens market, and what is the competitive landscape like?
  • How are vacuum ovens manufactured?

Key Attributes:

Report Attribute Details
No. of Pages 139
Forecast Period 2022 – 2028
Estimated Market Value (USD) in 2022 $254.3 Million
Forecasted Market Value (USD) by 2028 $343.2 Million
Compound Annual Growth Rate 5.1%
Regions Covered Global

For more information about this report visit https://www.researchandmarkets.com/r/n83xum

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment 



 


													

													

														Continue Reading
													

												

											

										

																	

							

													

						

													

						
			

				Advertisement
				
			

		

		

		
Latest news

		

		
			
											

				

							

					

						Trending on Grassnews
					

					
				

						

		

		

			

			

				
				

					

						

							
GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..


Contact us: sales@hipther.agency


Editorial / PR Submissions


Copyright © 2007 - 2023 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania